The Broccoli Company, a Swedish-based multi-level marketing (MLM) firm operating exclusively in Europe, markets nutritional products centered on sulforaphane, a compound derived from broccoli. Founded in 2010 in Mölndal, Sweden, the company represents the latest iteration of a business entity with a history of name changes and encounters with regulatory authorities across its three-decade existence. Its operational model relies on a unilevel compensation structure that requires affiliates to make recurring product purchases to qualify for commissions.
The company's origins trace back to 1993, when Magnus Ahlén and Lars Olof Mürbeck established Nature's Own. While headquartered in Sweden, Nature's Own primarily cultivated its affiliate network in Norway. This focus led to scrutiny from Norwegian authorities in 1998, who alleged the company violated Section 16 of the Norwegian Lottery Act. The core of the authorities' claim centered on Nature's Own's requirement for affiliates to purchase products as a precondition for earning commissions. Despite these claims, public prosecutors in the Norwegian county of Møre og Romsdal ultimately declined to pursue the case, which allowed Nature's Own to continue its operations in Norway without further legal action from the state regarding the Lottery Act.
Four years later, in 2002, Nature's Own faced a civil lawsuit initiated by Fred Thorkildsen, one of the company's prominent affiliates. While the specific grounds for Thorkildsen's legal action were not detailed, reports from the period indicated a significant decline in Nature's Own's growth, with its business operations experiencing a dramatic collapse in the years leading up to the lawsuit. This period of stagnation and subsequent decline, coupled with the prior regulatory claims by Norwegian authorities and persistent negative media coverage associated with the brand, prompted the company to undergo a rebranding. Nature's Own subsequently changed its name to Natures of Scandinavia.
The Natures of Scandinavia era saw further changes in leadership and ownership. In early 2006, Lars Olof Mürbeck divested his stake in the company. The following year, in 2007, Magnus Ahlén formed a new partnership with Scen Mattsson. Mattsson brought experience from the direct selling industry, having previously served as the Chief Executive Officer of Oriflame Cosmetics, another Swedish multi-level marketing enterprise established in 1967. Upon Mattsson's arrival, Magnus Ahlén publicly stated, "we have a very exciting future, in parallel with that there will be a new start for the company." This declaration signaled an intention for a renewed strategic direction. The company continued under the Natures of Scandinavia name for three years until 2010, when it rebranded for a second time, adopting its current identity as The Broccoli Company.
The product line offered by The Broccoli Company is centered on "organic broccoli-based nutritional products." The company asserts that "Groundbreaking research shows that broccoli nutrient, Sulforaphane, slows down the cell's ageing process, in the brain and in the body." The company also references Professor Peter Eriksson of Sahlgrenska University Hospital, stating that he was the first globally to demonstrate the human body's capacity to repair damaged brain cells and generate new ones continuously. The Broccoli Company claims it collaborated with Professor Eriksson to formulate a nutritional supplement designed to protect and stimulate a deceleration of the cellular aging process in both the brain and body. This formulation, named Synopticode 1236, is described as a combination of quality-assured, organic broccoli, turmeric, and selenium, with the results integrated into the company’s product offerings. At the time of publication, online searches for "Synopticode 1236" yield only nine results, all of which are directly connected to The Broccoli Company.
In contrast, searches for "Sulforaphane" provide more extensive information. Wikipedia describes sulforaphane as a molecule belonging to the isothiocyanate group of organosulfur compounds. It is noted for exhibiting anti-cancer and antimicrobial properties in experimental models. Sulforaphane is naturally obtained from cruciferous vegetables such as broccoli, Brussels sprouts, and cabbages. Its production occurs when the enzyme myrosinase converts glucoraphanin, a glucosinolate, into sulforaphane. This transformation typically happens when the plant tissue is damaged, for instance, through chewing, which allows the two precursor compounds to mix and react. Utilizing sulforaphane as its primary ingredient, The Broccoli Company distributes a broad array of products across various categories, including health, personal care, fitness, nutrition, and weight management.
The compensation plan implemented by The Broccoli Company employs a unilevel structure. In this model, an affiliate occupies the top position of their personal recruitment tree. All individuals personally recruited by this affiliate are placed directly on their first level. Should any of these first-level affiliates recruit new individuals, those new recruits are positioned on the second level of the original affiliate's structure. This pattern continues down through six distinct levels of recruitment. To qualify for commissions on product orders placed by their downline, affiliates must meet specific monthly purchase requirements. To earn commissions from their personally recruited affiliates (level 1), an affiliate must spend a minimum of 75 EUR on products each month. For an affiliate to qualify for commissions across all six available levels of their unilevel structure, they are required to make a personal monthly product order of at least 150 EUR and ensure their group generates a total order volume of at least 600 EUR per month, which includes their own purchases.
The historical regulatory challenges faced by Nature's Own, particularly the allegations under the Norwegian Lottery Act regarding required product purchases for commission eligibility, highlight a recurring point of contention within multi-level marketing business models. While public prosecutors in Norway did not pursue the case, the accusation itself underscores the potential for such structures to be scrutinized as pyramid schemes in certain jurisdictions if the emphasis shifts from product sales to recruitment and mandatory purchases. The subsequent lawsuit by a top affiliate and sustained negative media attention further suggest difficulties in maintaining affiliate satisfaction and public confidence, ultimately necessitating multiple brand changes to mitigate these perceptions. The company's current reliance on a unilevel compensation plan, which mandates monthly product purchases for commission eligibility, maintains a structural element that has historically drawn regulatory attention in the direct selling industry. Furthermore, the claims regarding sulforaphane and the proprietary "Synopticode 1236," for which independent scientific search results are scarce, place the burden of substantiation largely on the company itself. The business model's continued operation within the MLM framework, despite its past issues, underscores the enduring appeal and challenges of this distribution method.